Results 41 to 50 of about 34,204 (229)
Use of Brentuximab Vedotin in a Non-HIV Patient with Primary Effusion Lymphoma
Primary effusion lymphoma is a rare and aggressive large B-cell lymphoma presenting as malignant effusion with poor prognosis. Although it is more prevalent among HIV patients, it has also been described in non-HIV immunocompromised individuals.
Joana Ferra +5 more
doaj +1 more source
Kaposi's sarcoma-associated herpesvirus oncoprotein K13 protects against B cell receptor induced growth arrest and apoptosis through NF-κB activation [PDF]
Kaposi's sarcoma-associated herpesvirus (KSHV) has been linked to the development of Kaposi's sarcoma, primary effusion lymphoma and multicentric Castleman's disease (MCD). We have characterized the role of KSHV-encoded viral FLICE inhibitory protein K13
Ahmad +53 more
core +1 more source
Primary Effusion Lymphoma Diagnosed by Pericardiocentesis [PDF]
Primary effusion lymphoma (PEL), formerly known as body cavity-based lymphoma, is a high-grade B-cell non-Hodgkin's lymphoma associated with Kaposi's sarcoma and human herpesvirus 8 infection. It usually affects serous body cavities and results in recurrent lymphomatous effusions. PEL is often diagnosed in patients with HIV infection and carries a poor
Michael C, Nemunaitis +4 more
openaire +2 more sources
Extrahepatic complications of liver transplantation. [PDF]
The massive surgical assault associated with hepatic transplantation makes a high frequency of complications almost inevitable. In this review of 225 patient records, selected at random from cases of liver transplantation in Pittsburgh over a 2 1/2 year ...
Shaw, BW, Starzl, TE, Wood, RP
core +1 more source
Extracavitary primary effusion lymphoma presenting as a solitary brain mass
Primary effusion lymphoma (PEL) is an uncommon B-cell lymphoma associated with human herpesvirus 8 and comprises 3–4% of all HIV-related lymphomas.
Tiffany Javadi +5 more
doaj +1 more source
Primary effusion lymphoma and its tissue-based subtype extracavitary/solid variant was first described in human immunodeficiency virus (HIV)-seropositive patients.
Beril Guler, Guven Cetin
doaj +1 more source
The activation of KSHV lytic cycle blocks autophagy in PEL cells [PDF]
This study confirms that autophagy is activated concomitantly with KSHV lytic cycle induction, and that autophagy inhibition by BECN1 knockdown reduces viral lytic gene expression.
CIRONE, Mara +7 more
core +1 more source
Primary effusion lymphoma with skin involvement [PDF]
Primary effusion lymphoma (PEL) was once defined as a body cavity-based lymphoma without identifiable contiguous tumour mass, but is now recognised as an independent clinicopathological entity. The case of a 67-year-old Japanese woman with PEL is reported, in which the clinical findings showed a pericardial effusion and multiple erythema on the ...
S, Inoue +5 more
openaire +2 more sources
Introduction Primary effusion lymphoma is a recently recognized entity of AIDS related non-Hodgkin lymphomas. Despite Africa being greatly affected by the HIV/AIDS pandemic, an extensive MEDLINE/PubMed search failed to find any report of primary effusion
Osuwat Lawrence O +7 more
doaj +1 more source
‘Discovering’ primary effusion lymphoma in Malawi [PDF]
Primary effusion lymphoma (PEL) is a rare non-Hodgkin lymphoma (NHL) associated with human herpesvirus 8 (HHV8) and increased incidence among HIV-positive individuals. PEL rarely presents as solid tumor masses, or extracavitary PEL (EPEL). We found one case of PEL and no EPEL reported from sub-Saharan Africa (SSA), despite high prevalence of HIV and ...
Montgomery, Nathan D +14 more
openaire +1 more source

